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PRELIMINARY AND SHORT REPORTS
DEVELOPMENT OF REFRACTORY CONDITION OF SKIN TOWARDS ANTI-
HISTAMINIC DRUGS AFTER ANTI-HISTAMINIC THERAPY AS
DETERMINED BY HISTAMINE IONTOPHORESIS
SAMUEL MONASH, M. D.
This research was begun in an attempt to prolong the action of anti-histaminic drugs by
using the comparatively water insoluble anti-histaminic base parenteraiiy. Having obser-
ved (1), that substantially water insoluble procaine base in aqueous suspension will pro-
duce local anesthesia lasting, in some concentrations, more than two weeks, it seemed
possible that a similar result could be obtained with the bases of the anti-histaminic salts.
The method used in determining the anti-histaminie activity of a drug was the one that
has already been employed by a number of investigators. It consists in determining in-
creased resistance of the skin to whealing by histamine iontophoresis after prior ingestion
of the drug.
It was soon found that the results obtained were complicated by the formation of a re-
fractory state of the skin to the anti-histaminic drug. The dosage which originally produced
a marked change in the histamine reaction had later practically no effect. These experi-
ments were first performed on myself and subsequently on nine other individuals. The
dosage employed in testing was twice that usually recommended, such as 8 mg. for Chlortri-
meton,5 50 mg. for Thephorin(R) and 100 rng. for Pyribenzamine°). It was found that a
smaller dosage produced only a negligible change in the histamine reaction.
The results of the series of experiments upon myself follow:
8 mg. of Chlortrimeton Maleate) taken by mouth on an empty stomach produced a
marked lowering of the histamine reaction from a threshold of 1:3,000,000 to 1:100,000 at
the end of two hours and remained at 1:200,000 for the next 46 hours. At this time the in-
gestion of 100 mg. of Benadryl(') also produced a lowering of the histamine threshold and
subsequently 8 mg. of Chlortrimeton Maleate(R) had the same effect. Four days later the
intramuscular injection of 8 mg. of Chlortrimeton Maleateom) dissolved in 1 ml. of water
had a smaller effect than the 8 mg. taken by mouth in the first experiment, resulting in a
lowering of the reaction from 1:2,000,000 to 1:400,000 at 2- hours and a rapid return to
normal or 1:2,000,000 at 5 hours. The intramuscular injection, the following day, of 8 mg.
of Chlortrimeton' base, prepared in a syringe by adding sodium hydroxide to the Chlortri-
meton Maleate(R) solution to neutrality, had even less of an effect upon the histamine re-
action. From a threshold of 1:2,000,000, the reaction dropped only to 1:800,000 at the end
of 3 hours and returned to 1:1,000,000 in 4 hours.
I then injected intramuscularly 20 mg. or five times the usual dosage of Chlortrimeton
(R) base. This produced a marked lowering of the histamine reaction from 1:2,000,000 to
1:200,000 at three hours, and a gradual return to 1:000,000 in 37 hours. This effect was,
however, decidedly less than that of 8 mg. of the Chlortrimeton Ma1eate(') taken by mouth
nine days previously in the initial experiment.
Two days later, I took 100 mg. of Benadryl°) by mouth with practically no effect upon
the histamine reaction. From a threshold of 1:3,000,000 there was a slight drop to 1:2,000,-
000 at the end of 1 hours and no further lowering in the next 12 hours. The following day,
I took 8 mg. of Chlortrimeton Maleate) by mouth. Again there was no significant change
in the histamine reaction, from 1:2,000,000 to 1:1,000,000 at one hour, persisting at the
latter level for at least 51 hours and showing a normal level of 1:2,000,000 at 13 hours.
Whereas initially the above dosage had produced a tremendous reaction which persisted
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for 48 hours, it now had practically noeffect on the histamine reaction. The skin had evi-
dently become refractory to an oral dose twice that usually employed clinically. This had
occurred after taking 150 mg. of Benadryl(n) by mouth, 16 mg. of Chlortrimeton Maleate
(a) by mouth, 8 mg. of Chlortrimeton Maleate(R) intramuscularly and the base from 28
mg. of Chlortrimeton Maleateca) intramuscularly. This is approximately equivalent to the
usual dose taken by mouth four times daily for four days.
The above experiments were repeated in modified form upon nine other patients, using
the following drugs. Chlortrimeton Maleate" in two cases, Thephorin° in one case and
Pyribenzamine' in six cases. The change in histamine reaction after taking twice the
usual dosage was first determined. Only patients who showed a marked lowering of this
reaction were used, because many individuals with no history of having previously taken
anti-histaminic drugs showed practically no reaction to an initial double dosage of an
anti-histaminic drug. After noting the threshold reaction, the patient was then given the
normal dosage twice daily for one week. The histamine reaction after a double dosage of
the drug was again determined. In eight of the above nine patients a similar refractory
state developed after fourteen tablets. In only one of the Pyribenzamine cases, did the
patient show a significant lowering of the histamine reaction after one week's dosage.
Even in this case the later reaction was decidedly smaller than the initial one.
The duration of this refractory state is under investigation. In my own case, it has
already persisted for four months. Whether it indicates a diminution in therapeutic effect
is a subject for future investigation.
The following precautions were necessary to obtain consistent results in histamine
iontophoresis:(1) Freshly boiled distilled water should be used in making dilutions of histamine
phosphate.(2) Very dilute solutions deteriorate rapidly. They must be freshly prepared not later
than every four hours. They may be made from a concentrated solution of 1:500 of hista-
mine phosphate, which maintains its potency for about a week.
(3) If tests are repeated on the same individual, the threshold reaction must be rede-
termined on the day of testing.
(4) The threshold is taken as the most dilute solution which produces follicular
whealing.(5) Repeated tests must not be made on the same area, because such repeated tests
produce a reaction higher than that on previously untested skin and in addition a mild
contact dermatitis.
(6) The anti-histaminic drug should be given on an empty stomach.
sualalAav
In nine out of ten individuals tested, the prior ingestion of a comparatively
small amount of an anti-histaminic drug resulted in the formation of a refractory state of
the skin to the anti-histaminic drug used. In one case, my own, in which two anti-hista-
minic drugs had been taken previously, the skin became refractory to both.
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